BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 24334432)

  • 21. The difference of burden of ectopic beats in different types of atrial fibrillation and the effect of atrial fibrillation type on stroke risk in a prospective cohort of patients with atrial fibrillation (CODE-AF registry).
    Cho S; Kim J; Kim JB; Park J; Park JK; Kang KW; Shim J; Choi EK; Lee YS; Park HW; Joung B
    Sci Rep; 2020 Apr; 10(1):6319. PubMed ID: 32286428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices.
    Martin DT; Bersohn MM; Waldo AL; Wathen MS; Choucair WK; Lip GY; Ip J; Holcomb R; Akar JG; Halperin JL;
    Eur Heart J; 2015 Jul; 36(26):1660-8. PubMed ID: 25908774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rationale and Design of the Evaluation of Oral Anticoagulation for Reduction of Thrombo-embolism in Chinese Patients with Device-Detected Subclinical Atrial Fibrillation (ART-CAF) Trial: an Open-Label Registry-Based Clinical Trial.
    Yang Y; Xu F; Tong J; Cai L; Jiang W; Sheng X; Pan Y; Jiang J; Zhang J; Jiang D; Zhao L; Fu G
    Cardiovasc Drugs Ther; 2018 Aug; 32(4):389-396. PubMed ID: 30027309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).
    Rohla M; Weiss TW; Pecen L; Patti G; Siller-Matula JM; Schnabel RB; Schilling R; Kotecha D; Lucerna M; Huber K; De Caterina R; Kirchhof P
    BMJ Open; 2019 Mar; 9(3):e022478. PubMed ID: 30928922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation.
    Black-Maier E; Kim S; Steinberg BA; Fonarow GC; Freeman JV; Kowey PR; Ansell J; Gersh BJ; Mahaffey KW; Naccarelli G; Hylek EM; Go AS; Peterson ED; Piccini JP;
    Clin Cardiol; 2017 Sep; 40(9):746-751. PubMed ID: 28543401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Dx-AF study: a prospective, multicenter, randomized controlled trial comparing VDD-ICD to VVI-ICD in detecting sub-clinical atrial fibrillation in defibrillator patients.
    Shurrab M; Janmohamed A; Sarrazin JF; Ayala-Paredes F; Sturmer M; Williams R; Toal S; Lane C; Thorpe KE; Healey JS; Crystal E
    J Interv Card Electrophysiol; 2017 Oct; 50(1):57-63. PubMed ID: 28752228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atrial fibrillation burden and atrial fibrillation type: Clinical significance and impact on the risk of stroke and decision making for long-term anticoagulation.
    Boriani G; Pettorelli D
    Vascul Pharmacol; 2016 Aug; 83():26-35. PubMed ID: 27196706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of cardiovascular implantable electronic devices in delivering individualized disease-guided management of patients with non-valvular atrial fibrillation and high bleeding risk.
    Mascarenhas DAN; Sharma M; Ziegler PD; Kantharia BK
    Acta Cardiol; 2019 Apr; 74(2):131-139. PubMed ID: 29863432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of insertable cardiac monitors in anticoagulation therapy in patients with atrial fibrillation at high risk of bleeding.
    Mascarenhas DA; Farooq MU; Ziegler PD; Kantharia BK
    Europace; 2016 Jun; 18(6):799-806. PubMed ID: 26614520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and Efficacy of Rivaroxaban in Patients With Cardiac Implantable Electronic Devices: Observations From the ROCKET AF Trial.
    Leef GC; Hellkamp AS; Patel MR; Becker RC; Berkowitz SD; Breithardt G; Halperin JL; Hankey GJ; Hacke W; Nessel CC; Singer DE; Fox KAA; Mahaffey KW; Piccini JP
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28615214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of Atrial Fibrillation in Black Versus White Medicare Beneficiaries With Implanted Cardiac Devices.
    Chen ML; Parikh NS; Merkler AE; Kleindorfer DO; Bhave PD; Levitan EB; Soliman EZ; Kamel H
    J Am Heart Assoc; 2019 Feb; 8(4):e010661. PubMed ID: 30741594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patients aged 90 years or older with atrial fibrillation treated with oral anticoagulants: A multicentre observational study.
    Giustozzi M; Vedovati MC; Verso M; Scrucca L; Conti S; Verdecchia P; Bogliari G; Pierpaoli L; Agnelli G; Becattini C
    Int J Cardiol; 2019 Apr; 281():56-61. PubMed ID: 30712846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between ventricular pacing and persistent atrial fibrillation in patients indicated to elective pacemaker replacement: Results of the Prefer for Elective Replacement MVP (PreFER MVP) randomized study.
    Ricci RP; Botto GL; Bénézet JM; Nielsen JC; De Roy L; Piot O; Quesada A; Quaglione R; Vaccari D; Mangoni L; Grammatico A; Kozák M;
    Heart Rhythm; 2015 Nov; 12(11):2239-46. PubMed ID: 26142300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stroke risk in hypertrophic cardiomyopathy patients with atrial fibrillation: a nationwide database study.
    Hsu JC; Huang YT; Lin LY
    Aging (Albany NY); 2020 Nov; 12(23):24219-24227. PubMed ID: 33226371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arrhythmic Burden and the Risk of Cardiovascular Outcomes in Patients With Paroxysmal Atrial Fibrillation and Cardiac Implanted Electronic Devices.
    Chew DS; Li Z; Steinberg BA; O'Brien EC; Pritchard J; Bunch TJ; Mark DB; Patel MR; Nabutovsky Y; Greiner MA; Piccini JP
    Circ Arrhythm Electrophysiol; 2022 Feb; 15(2):e010304. PubMed ID: 35089799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does atrial fibrillation detected by cardiac implantable electronic devices have clinical relevance?
    Glotzer TV; Ziegler PD
    Cardiol Clin; 2014 May; 32(2):271-81. PubMed ID: 24793802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for the development of incident atrial fibrillation in patients with cardiac implantable electronic devices.
    Miyazawa K; Kondo Y; Nakano M; Esteve-Pastor MA; Rivera-Caravaca JM; Senoo K; Kobayashi Y; Lip GYH
    Eur J Intern Med; 2018 Jun; 52():54-59. PubMed ID: 29490874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atrial Fibrillation Burden and Short-Term Risk of Stroke: Case-Crossover Analysis of Continuously Recorded Heart Rhythm From Cardiac Electronic Implanted Devices.
    Turakhia MP; Ziegler PD; Schmitt SK; Chang Y; Fan J; Than CT; Keung EK; Singer DE
    Circ Arrhythm Electrophysiol; 2015 Oct; 8(5):1040-7. PubMed ID: 26175528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atrial Fibrillation Diagnosis Timing, Ambulatory ECG Monitoring Utilization, and Risk of Recurrent Stroke.
    Lip GY; Hunter TD; Quiroz ME; Ziegler PD; Turakhia MP
    Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28096204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.